However, the presence of lower peripheral adiponectin levels could promote the development of dyslipidaemia through several deleterious mechanisms (obesity, chronic inflammation, insulin resistance, blood pressure deregulation, and changes in the lipid profile) [37]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.